Elicio Therapeutics Inc. Market Cap History

Market Cap: $75.2 Million

USD as of Aug 2, 2026

Company Profile $ELTX

Elicio Therapeutics Inc. Market Capitalization Over Time

Evolution of Elicio Therapeutics Inc. market cap history

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Yearly Market Cap Evolution

Date Market Cap YoY Change

Market capitalization is calculated from the opening stock price at the beginning of each year.

Company Description

Profile

Elicio Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel immunotherapies for the treatment of cancer. The company engineers next-generation vaccines, immunomodulators, and adjuvants built on its proprietary lymph node–targeting Amphiphile (AMP) platform, designed to enhance the education, activation, and amplification of cancer-specific T cells. Its lead program, ELI-002, is an off-the-shelf, lymph node–targeted therapeutic vaccine candidate directed at the most common KRAS mutations implicated across a broad range of solid tumors, including pancreatic and colorectal cancers. By concentrating immune stimulation in lymph nodes, Elicio Therapeutics aims to generate potent and durable anti-tumor immune responses in high-prevalence, hard-to-treat cancers. The company maintains a diversified oncology pipeline based on the AMP platform, including AMP-powered cancer vaccines and AMP-DNA adjuvant technologies under clinical and preclinical development. Elicio Therapeutics is headquartered in Boston, Massachusetts, and operates within the global biotechnology and oncology research ecosystem.

Stocks & Indexes

Elicio Therapeutics Inc. main stocks and indexes inclusions.

$ELTX
Russell 2000 Russell 3000

What is Market Capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.